Good Manufacturing Practices (GMPs) from an IND Perspective (11of14) REdI 2018
Рет қаралды 5,785
Күн бұрынCDER’s Maria Cecilia Tami discusses GMPs pertinent to INDs with an emphasis on the relevant guidances.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2018 Playlist: • 2018 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
U.S. Food and Drug Administration
Рет қаралды 3 М.
U.S. Food and Drug Administration
Рет қаралды 28 М.
U.S. Food and Drug Administration
Рет қаралды 4,4 М.
U.S. Food and Drug Administration
Рет қаралды 12 М.
U.S. Food and Drug Administration
Рет қаралды 390
U.S. Food and Drug Administration
Рет қаралды 2,7 М.
U.S. Food and Drug Administration
Рет қаралды 1,9 М.
U.S. Food and Drug Administration
Рет қаралды 4,6 М.
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
U.S. Food and Drug Administration
Рет қаралды 3,7 М.
Demystifying the Investigational New Drug (IND) Application for Drugs and Biologics (3of14) REdI '18
U.S. Food and Drug Administration
Рет қаралды 5 М.
U.S. Food and Drug Administration
Рет қаралды 4,1 М.